{{Rsnum
|rsid=7527074
|Gene=XPR1
|Chromosome=1
|position=180676305
|Orientation=plus
|GMAF=0.03949
|Gene_s=XPR1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 99.3 | 0.7 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 67.8 | 30.8 | 1.4
| ASW | 75.0 | 25.0 | 0.0
| CHB | 99.3 | 0.7 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 70.0 | 26.4 | 3.6
| MEX | 96.4 | 3.6 | 0.0
| MKK | 80.8 | 17.9 | 1.3
| TSI | 99.0 | 1.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23829686
  |Trait=Asthma (childhood onset)
  |Title=Rank-based genome-wide analysis reveals the association of ryanodine receptor-2 gene variants with childhood asthma among human populations.
  |RiskAllele=
  |Pval=9E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}